Stephen Gordon - 01 Feb 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
Chief Financial Officer
Signature
By: /s/ Stephen Gordon
Issuer symbol
TMDX
Transactions as of
01 Feb 2023
Net transactions value
-$232,500
Form type
4
Filing time
03 Feb 2023, 16:06:24 UTC
Previous filing
18 Jan 2023
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $80,700 +5,000 +88% $16.14* 10,714 01 Feb 2023 Direct F1
transaction TMDX Common Stock Sale $313,200 -5,000 -47% $62.64 5,714 01 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -5,000 -19% $0.000000 20,728 01 Feb 2023 Common Stock 5,000 $16.14 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
F2 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024.